Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Patients in Europe are eager to be more involved in the process of developing treatments, CSL’s Sylvia Herget said. The high-…
It’s dangerous when kids bounce together – especially for a child who has a bleeding disorder, experts say. For advice, ask y…
As a young person moves into adulthood, it can be time to thank Mom and Dad, tap into their knowledge as caregivers and start…
Iron is an essential mineral that supports necessary functions in the body, including transporting oxygen. Without enough, fa…
Meet CSL Seqirus’ Global Health Economic and Value Strategy Director, a data aficionado, family historian and avid soccer fan…
June 28 Is International Neonatal Screening Day. We share three key facts from the advocacy groups that are leading the way.
The 2023 Heimburger Award goes to five promising scientists investigating coagulation, thrombosis and acquired bleeding disor…
The global biotech company ranks among the top 500 on the list compiled annually by the century-old business magazine.
People with rare and serious diseases depend on plasma-derived medicines, which will be impacted by pending legislation in Eu…
Americas
Asia Pacific
Middle East
Europe